A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

NCT07650357 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Non Small Cell Lung Cancer
Pancreatic Carcinoma
Colorectal Cancer

Interventions

DRUG: CLSP-5282

Sponsor

Clasp Therapeutics, Inc.